Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
101.6 USD | -0.10% | -0.27% | +21.63% |
May. 07 | UBS Adjusts Cabot Price Target to $103 From $100, Maintains Neutral Rating | MT |
May. 07 | Mizuho Adjusts Price Target on Cabot to $109 From $104, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 3.99B | Sales 2025 * | 4.25B | Capitalization | 5.61B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.64 x |
Net Debt 2024 * | 947M | Net Debt 2025 * | 914M | EV / Sales 2025 * | 1.53 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 4,268 |
Yield 2024 * |
1.66% | Yield 2025 * |
1.81% | Free-Float | 98.61% |
Latest transcript on Cabot Corporation
1 day | -0.10% | ||
1 week | -0.27% | ||
Current month | +11.32% | ||
1 month | +9.57% | ||
3 months | +24.29% | ||
6 months | +29.64% | ||
Current year | +21.63% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Keohane
CEO | Chief Executive Officer | 56 | 02-07-31 |
Erica McLaughlin
DFI | Director of Finance/CFO | 48 | 02-03-31 |
Patricia Hubbard
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-02-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Kirby
BRD | Director/Board Member | 72 | 12-07-09 |
Sean Keohane
CEO | Chief Executive Officer | 56 | 02-07-31 |
Ying Yan
BRD | Director/Board Member | 58 | 19-05-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 43 M€ | +4.31% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 101.6 | -0.10% | 279,852 |
24-05-15 | 101.7 | -0.55% | 267,570 |
24-05-14 | 102.2 | +0.05% | 266,357 |
24-05-13 | 102.2 | +0.26% | 263,308 |
24-05-10 | 101.9 | +0.08% | 238,470 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+21.63% | 5.62B | |
+17.29% | 66.52B | |
+2.81% | 50.34B | |
+17.88% | 42.01B | |
+20.77% | 26.68B | |
+11.82% | 19.97B | |
+0.19% | 17.32B | |
-21.87% | 15.7B | |
+0.91% | 15.53B | |
-10.58% | 14.99B |
- Stock Market
- Equities
- CBT Stock